Impact of IPF on Quality of Life and Financial Considerations

Author(s):

Key Takeaways

IPF severely impacts quality of life, limiting daily activities due to progressive respiratory decline.
Median survival for IPF patients is approximately 3 to 5 years post-diagnosis.
The financial burden of IPF is significant, driven by hospitalizations, medication costs, and long-term oxygen therapy.
High healthcare resource utilization includes frequent outpatient visits, hospital admissions, and potential lung transplantation.

Toby Maher, MD, PhD, discusses how idiopathic pulmonary fibrosis (IPF) severely affects patients’ quality of life and daily functioning, with a median survival that underscores the disease’s severity, while also highlighting the substantial financial burden and health care resource utilization associated with managing this condition.

EP: 1.Emerging Agents in IPF Treatment

EP: 2.IPF and PDE4B Inhibitors

EP: 3.Importance of Patient-Reported Outcomes

EP: 4.Future Possibilities in IPF Treatment

EP: 5.Advice for Clinicians Treating IPF

EP: 6.Current Standard of Care in IPF

EP: 7.Therapeutic Response and Disease Progression

EP: 8.Key Considerations for Selecting IPF Treatment

EP: 9.Economic Impact of IPF

EP: 10.Unmet Needs in IPF Landscape

EP: 11.Overview of Idiopathic Pulmonary Fibrosis (IPF)

Now Viewing

EP: 12.Impact of IPF on Quality of Life and Financial Considerations

EP: 13.Diagnosing IPF: Key Tests, Time to Diagnosis, and Importance of Early Detection

EP: 14.Clinical Presentation and Risk Factors

EP: 15.Impact of Comorbidities on IPF Management

EP: 16.Overcoming Treatment Barriers: Strategies for Success

EP: 17.Impact of Treatment Delays on Patient Outcomes

Video content above is prompted by the following:

How does IPF impact a patient’s quality of life and ability to perform activities of daily living? What is the median survival for patients with IPF?
Can you describe the financial impact and health care resource utilization for patients with IPF?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!